BioCentury | Jan 27, 2017
Company News
TesoRx, Aska deal
...TesoRx granted Aska an exclusive option to develop and commercialize THG-1001 in Japan. TesoRx will receive...
...Japan. TesoRx will receive an undisclosed upfront payment and is eligible for milestones and royalties. THG-1001...
...Calif. Aska Pharmaceutical Co. Ltd. (Tokyo:4514), Tokyo, Japan Business: Endocrine/Metabolic Chris Lieu Aska Pharmaceutical Co. Ltd. TesoRx Pharma LLC THG-1001...
...Japan. TesoRx will receive an undisclosed upfront payment and is eligible for milestones and royalties. THG-1001...
...Calif. Aska Pharmaceutical Co. Ltd. (Tokyo:4514), Tokyo, Japan Business: Endocrine/Metabolic Chris Lieu Aska Pharmaceutical Co. Ltd. TesoRx Pharma LLC THG-1001...
